NIH RFA for T1D Research


NIH RFA 19-026: New Investigator Gateway Awards for Collaborative T1D Research

** Letter of Intent Due Date(s): February 25, 2020 & October 3, 2020 **


NIH has issued a “New Investigator Gateway Awards for Collaborative T1D Research” Funding Initiative. This initiative is similar to our internal HIRN New Investigator Initiative we held a few years ago – except that it’s being organized centrally at NIH (with more awards and more money!) and the applicants are encouraged to submit the group they would like to work with (HIRN, TEDDY or TrialNet).

  • Letter of Intent Due Date(s): February 25, 2020 and October 3, 2020
  • Application Due Date(s): March 25, 2020 and November 3, 2020
  • Scientific Merit Review: June/July 2020 and Feb/March 2021
  • Advisory Council Review: October 2020 and May 2021
  • Earliest Start Date: December 2020 and July 2021
  • Expiration Date: November 04, 2020

Funds Available and Anticipated Number of Awards
NIDDK intends to commit $3,500,000 in FY 2020 and FY2021 to fund up to 25 awards.

Award Budget
Applications may request budgets of up to $100,000 in direct costs per year for up to two years.

Award Project Period
The maximum project period is 2 years.

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.


Additional NIH Funding Opportunities 

  • RFA-DK-19-024 Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas
    • Application Due Date: April 1, 2020
    • Foreign applications allowed
  • RFA-DK-19-027 Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
    • Application due dates: April 9, 2020 and October 3, 2020
    • Foreign applications not allowed
  • F31 PAR-19-378: Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases
  • F32 PAR-19-379: Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases
    • Application Due Date:  Standard dates apply
    • Foreign applications allowed
  • RFA-PAR-18-886 : New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
    • Letter of Intent due: Six weeks prior to application due date
    • Application due dates: October 31, 2019; June 2, 2020